RaySearch Laboratories AB (publ) Interim Report, January 1 – March 31, 2005

•Net sales for the period amounted to SEK 13.1 M (10.1)

•Profit after tax totaled SEK 4.5 M (3.5)

•Earnings per share after tax amounted to SEK 0.40 (0.33)

•Operating profit amounted to SEK 6.2 M (4.9)

•Cash flow from operating activities amounted to SEK 6.7 M (3.2)


For further information, contact:
Johan Löf, President and CEO
RaySearch Laboratories AB
Telephone: 08-545 061 30
 

RaySearch Laboratories

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners su...

View more


  CONTACT  

Related documents

 
 
 
 
Social Media Pitch:
RaySearch Laboratories AB (publ) Interim Report, January 1 – March 31, 2005